News stories about 22nd Century Group (NYSE:XXII) have trended somewhat positive recently, Accern Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. 22nd Century Group earned a coverage optimism score of 0.10 on Accern’s scale. Accern also gave media headlines about the biotechnology company an impact score of 45.9718351080398 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

These are some of the media headlines that may have effected Accern Sentiment’s analysis:

A number of equities analysts recently issued reports on the company. Zacks Investment Research raised 22nd Century Group from a “sell” rating to a “hold” rating and set a $3.00 price target on the stock in a report on Wednesday, October 18th. Chardan Capital raised their price target on 22nd Century Group from $3.50 to $11.50 and gave the stock a “buy” rating in a report on Monday, October 16th.

22nd Century Group (NYSE:XXII) opened at $1.99 on Monday. 22nd Century Group has a twelve month low of $0.81 and a twelve month high of $3.50.

In other 22nd Century Group news, VP Michael Robert Moynihan sold 50,000 shares of 22nd Century Group stock in a transaction that occurred on Friday, September 29th. The stock was sold at an average price of $2.67, for a total value of $133,500.00. Following the sale, the vice president now owns 867,220 shares of the company’s stock, valued at approximately $2,315,477.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

COPYRIGHT VIOLATION NOTICE: “Somewhat Favorable Media Coverage Somewhat Unlikely to Affect 22nd Century Group (XXII) Stock Price” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of US & international copyright laws. The correct version of this piece of content can be viewed at

About 22nd Century Group

Insider Buying and Selling by Quarter for 22nd Century Group (NYSE:XXII)

Receive News & Stock Ratings for 22nd Century Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group Inc and related stocks with our FREE daily email newsletter.